NAD+
Regulatory status
Not an approved drug substance in the United States and not on the 503A bulks list. Available to verified facilities for research and manufacturing use only.
Summary
NAD+ is a nucleotide cofactor rather than a peptide, supplied as a hygroscopic white to off-white powder. It is unusually sensitive to moisture and to elevated temperature, and lots degrade measurably in transit when shipped without temperature control.
Because it is not a peptide, the peptide content figure does not apply; assay by HPLC against a reference standard and water content by Karl Fischer are the two numbers that matter for price comparison.
Typical related substances
Typical related substances are nicotinamide, nicotinamide mononucleotide, ADP-ribose and hydrolysis products formed on moisture exposure.
Regulatory note
Not an approved drug substance in the United States and not on the 503A bulks list.
Regulatory status shown is our current understanding and is not legal advice. Each facility is responsible for confirming eligibility for its own licence type before purchase.